Summary
The Cigna Group (CI) filed an 8-K on December 11, 2023, primarily to affirm its previously issued 2023 financial outlook and provide updated capital deployment plans. The company reaffirmed its projected full-year 2023 consolidated adjusted income from operations per share of at least $24.75. Looking ahead, Cigna has set a target for full-year 2024 consolidated adjusted income from operations per share of at least $28.00. In addition to the financial guidance, Cigna announced a significant increase in its share repurchase authorization. The Board of Directors approved an additional $10 billion in incremental authorization, bringing the total to $11.3 billion. The company intends to deploy a substantial portion of its discretionary cash flow towards share repurchases in 2024, including at least $5 billion of common stock by the end of the first half of 2024, with a portion to be executed through an accelerated share repurchase program in Q1 2024. This increased buyback program signals management's confidence in the company's financial health and its commitment to returning capital to shareholders.
Key Highlights
- 1Reaffirmed 2023 full-year adjusted income from operations per share outlook of at least $24.75.
- 2Set a 2024 full-year adjusted income from operations per share target of at least $28.00.
- 3Board approved an aggregate increase of $10 billion in share repurchase authorization, bringing the total to $11.3 billion.
- 4Intends to use the majority of discretionary cash flow for share repurchases in 2024.
- 5Plans to repurchase at least $5 billion of common stock between now and the end of H1 2024.
- 6A portion of the repurchase will be executed via an accelerated share repurchase (ASR) program in Q1 2024.